These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 24029003

  • 1. Modulating mGluR5 and 5-HT1A/1B receptors to treat l-DOPA-induced dyskinesia: effects of combined treatment and possible mechanisms of action.
    Iderberg H, Rylander D, Bimpisidis Z, Cenci MA.
    Exp Neurol; 2013 Dec; 250():116-24. PubMed ID: 24029003
    [Abstract] [Full Text] [Related]

  • 2. Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia.
    Muñoz A, Li Q, Gardoni F, Marcello E, Qin C, Carlsson T, Kirik D, Di Luca M, Björklund A, Bezard E, Carta M.
    Brain; 2008 Dec; 131(Pt 12):3380-94. PubMed ID: 18952677
    [Abstract] [Full Text] [Related]

  • 3. Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesia.
    Bézard E, Muñoz A, Tronci E, Pioli EY, Li Q, Porras G, Björklund A, Carta M.
    Neurosci Res; 2013 Dec; 77(4):242-6. PubMed ID: 24135129
    [Abstract] [Full Text] [Related]

  • 4. Serotonin 1B receptor stimulation reduces D1 receptor agonist-induced dyskinesia.
    Jaunarajs KL, Dupre KB, Steiniger A, Klioueva A, Moore A, Kelly C, Bishop C.
    Neuroreport; 2009 Sep 23; 20(14):1265-9. PubMed ID: 19633584
    [Abstract] [Full Text] [Related]

  • 5. The anti-dyskinetic effect of dopamine receptor blockade is enhanced in parkinsonian rats following dopamine neuron transplantation.
    Shin E, Lisci C, Tronci E, Fidalgo C, Stancampiano R, Björklund A, Carta M.
    Neurobiol Dis; 2014 Feb 23; 62():233-40. PubMed ID: 24135006
    [Abstract] [Full Text] [Related]

  • 6. Effects of 5-HT1A receptor stimulation on striatal and cortical M1 pERK induction by L-DOPA and a D1 receptor agonist in a rat model of Parkinson's disease.
    Lindenbach D, Dupre KB, Eskow Jaunarajs KL, Ostock CY, Goldenberg AA, Bishop C.
    Brain Res; 2013 Nov 06; 1537():327-39. PubMed ID: 24060645
    [Abstract] [Full Text] [Related]

  • 7. Contribution of the striatum to the effects of 5-HT1A receptor stimulation in L-DOPA-treated hemiparkinsonian rats.
    Bishop C, Krolewski DM, Eskow KL, Barnum CJ, Dupre KB, Deak T, Walker PD.
    J Neurosci Res; 2009 May 15; 87(7):1645-58. PubMed ID: 19115412
    [Abstract] [Full Text] [Related]

  • 8. Activity of serotonin 5-HT(1A) receptor 'biased agonists' in rat models of Parkinson's disease and L-DOPA-induced dyskinesia.
    Iderberg H, McCreary AC, Varney MA, Cenci MA, Newman-Tancredi A.
    Neuropharmacology; 2015 Jun 15; 93():52-67. PubMed ID: 25645393
    [Abstract] [Full Text] [Related]

  • 9. 5-Hydroxy-tryptophan for the treatment of L-DOPA-induced dyskinesia in the rat Parkinson's disease model.
    Tronci E, Lisci C, Stancampiano R, Fidalgo C, Collu M, Devoto P, Carta M.
    Neurobiol Dis; 2013 Dec 15; 60():108-14. PubMed ID: 24004632
    [Abstract] [Full Text] [Related]

  • 10. Effects of coincident 5-HT1A receptor stimulation and NMDA receptor antagonism on L-DOPA-induced dyskinesia and rotational behaviors in the hemi-parkinsonian rat.
    Dupre KB, Eskow KL, Steiniger A, Klioueva A, Negron GE, Lormand L, Park JY, Bishop C.
    Psychopharmacology (Berl); 2008 Jul 15; 199(1):99-108. PubMed ID: 18545986
    [Abstract] [Full Text] [Related]

  • 11. Cellular and behavioral effects of 5-HT1A receptor agonist 8-OH-DPAT in a rat model of levodopa-induced motor complications.
    Ba M, Kong M, Ma G, Yang H, Lu G, Chen S, Liu Z.
    Brain Res; 2007 Jan 05; 1127(1):177-84. PubMed ID: 17113046
    [Abstract] [Full Text] [Related]

  • 12. L-stepholidine reduced L-DOPA-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease.
    Mo J, Zhang H, Yu LP, Sun PH, Jin GZ, Zhen X.
    Neurobiol Aging; 2010 Jun 05; 31(6):926-36. PubMed ID: 18707801
    [Abstract] [Full Text] [Related]

  • 13. Striatal 5-HT1A receptor stimulation reduces D1 receptor-induced dyskinesia and improves movement in the hemiparkinsonian rat.
    Dupre KB, Eskow KL, Barnum CJ, Bishop C.
    Neuropharmacology; 2008 Dec 05; 55(8):1321-8. PubMed ID: 18824001
    [Abstract] [Full Text] [Related]

  • 14. MDMA and fenfluramine reduce L-DOPA-induced dyskinesia via indirect 5-HT1A receptor stimulation.
    Bishop C, Taylor JL, Kuhn DM, Eskow KL, Park JY, Walker PD.
    Eur J Neurosci; 2006 May 05; 23(10):2669-76. PubMed ID: 16817869
    [Abstract] [Full Text] [Related]

  • 15. A serotonin 5-HT1A receptor agonist prevents behavioral sensitization to L-DOPA in a rodent model of Parkinson's disease.
    Tomiyama M, Kimura T, Maeda T, Kannari K, Matsunaga M, Baba M.
    Neurosci Res; 2005 Jun 05; 52(2):185-94. PubMed ID: 15893579
    [Abstract] [Full Text] [Related]

  • 16. L-DOPA treatment selectively restores spine density in dopamine receptor D2-expressing projection neurons in dyskinetic mice.
    Suárez LM, Solís O, Caramés JM, Taravini IR, Solís JM, Murer MG, Moratalla R.
    Biol Psychiatry; 2014 May 01; 75(9):711-22. PubMed ID: 23769604
    [Abstract] [Full Text] [Related]

  • 17. Effect of the metabotropic glutamate receptor type 5 antagonists MPEP and MTEP in parkinsonian monkeys.
    Morin N, Grégoire L, Gomez-Mancilla B, Gasparini F, Di Paolo T.
    Neuropharmacology; 2010 Jun 01; 58(7):981-6. PubMed ID: 20074579
    [Abstract] [Full Text] [Related]

  • 18. Basal ganglia serotonin 1B receptors in parkinsonian monkeys with L-DOPA-induced dyskinesia.
    Riahi G, Morissette M, Samadi P, Parent M, Di Paolo T.
    Biochem Pharmacol; 2013 Oct 01; 86(7):970-8. PubMed ID: 23954709
    [Abstract] [Full Text] [Related]

  • 19. Behavioral and cellular dopamine D1 and D3 receptor-mediated synergy: Implications for L-DOPA-induced dyskinesia.
    Lanza K, Meadows SM, Chambers NE, Nuss E, Deak MM, Ferré S, Bishop C.
    Neuropharmacology; 2018 Aug 01; 138():304-314. PubMed ID: 29936243
    [Abstract] [Full Text] [Related]

  • 20. Serotonin neuron-dependent and -independent reduction of dyskinesia by 5-HT1A and 5-HT1B receptor agonists in the rat Parkinson model.
    Muñoz A, Carlsson T, Tronci E, Kirik D, Björklund A, Carta M.
    Exp Neurol; 2009 Sep 01; 219(1):298-307. PubMed ID: 19500572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.